Last Updated: May 10, 2026

CLINICAL TRIALS PROFILE FOR METOCLOPRAMIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for METOCLOPRAMIDE

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00003213 ↗	Drugs to Reduce the Side Effects of Chemotherapy	Completed	Swiss Group for Clinical Cancer Research	Phase 3	1996-05-01	RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients treated with chemotherapy. It is not known whether receiving dexamethasone with granisetron is more effective than receiving dexamethasone with metoclopramide for reducing the side effects of chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of dexamethasone with either granisetron or metoclopramide in patients treated with chemotherapy.
NCT00008736 ↗	Electrogastrography (EGC) in Premature Infants With Feeding Intolerance	Completed	Children's Hospital of Philadelphia	Phase 2	1969-12-31	Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.
NCT00008736 ↗	Electrogastrography (EGC) in Premature Infants With Feeding Intolerance	Completed	National Center for Research Resources (NCRR)	Phase 2	1969-12-31	Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for METOCLOPRAMIDE

Condition Name

Chart
Table

Condition Name for METOCLOPRAMIDE
Intervention	Trials
Nausea	21
Postoperative Nausea and Vomiting	16
Migraine	15
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for METOCLOPRAMIDE
Intervention	Trials
Vomiting	56
Nausea	47
Postoperative Nausea and Vomiting	34
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for METOCLOPRAMIDE

Trials by Country

Map
Table

Trials by Country for METOCLOPRAMIDE
Location	Trials
United States	230
Egypt	48
Canada	21
Australia	16
Turkey	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for METOCLOPRAMIDE
Location	Trials
New York	31
Texas	15
Pennsylvania	15
Illinois	12
Ohio	11
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for METOCLOPRAMIDE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for METOCLOPRAMIDE
Clinical Trial Phase	Trials
PHASE4	12
PHASE3	10
PHASE2	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for METOCLOPRAMIDE
Clinical Trial Phase	Trials
Completed	149
Recruiting	46
Not yet recruiting	31
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for METOCLOPRAMIDE

Sponsor Name

Chart
Table

Sponsor Name for METOCLOPRAMIDE
Sponsor	Trials
Assiut University	15
Montefiore Medical Center	15
Cairo University	14
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for METOCLOPRAMIDE
Sponsor	Trials
Other	358
Industry	37
NIH	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.